Skip to Content

Additional Content In This Section

OVERTURE

OVERTURE

Objective

Status
Enrollment complete

Condition
Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Description
A Multi-center, Longitudinal Observational Study of Patients with ADPKD to Establish the Rate, Characteristics, and Determinants of Disease Progression

Purpose
Identify which ADPKD patients are at risk for clinically relevant rapid disease progression

Phase
Observational

Key Inclusion Criteria

  • Ages 12 to 70 years, inclusive
  • Existing diagnosis of ADPKD by modified-Ravine criteria
  • Total kidney volume >= 300 cc/m height by ultrasound or >= 250 cc/m height by MRI

Key Exclusion Criteria
Current or expected (within the next six months) interventions for the treatment of ADPKD affecting kidney volume

ClinicalTrials.gov Identifier
NCT1430494

IRB Protocol Number
156-10-291
Principal Investigator(s)
Adetola Haastrup, MD
Ebima Okundaye, MD
Kelly Leach, NP

Clinical Trial Categories

  • Nephrology
Sponsor(s)
Otsuka Pharmaceutical
Contact
Renee Hendrickson, RN CCRC at 701-780-1694
or rhendrickson@altru.org